Agaricus blazei Murill - immunomodulatory properties and health benefits

Authors

  • R. Biedron International Science and Health Foundation, Cracow
  • J. M. Tangen Departmentts of Hematology and 4Cellular Therapy, Oslo University Hospital, Oslo
  • K. Maresz International Science and Health Foundation, Cracow
  • G. Hetland Cellular Therapy, Oslo University Hospital, Oslo

DOI:

https://doi.org/10.31989/ffhd.v2i11.72

Abstract

The Agaricus blazei Murill (AbM), also known as Agaricus brasiliensis L. due to its origin in Brazilian rain forest, is an edible mushroom of the Basidiomycetes family, which also comprises medicinal mushrooms such as Hericium erinaceus and Grifola frondosa. AbM has been used in traditional medicine locally and also recently as a health food worldwide. Since it has been found to possess immunomodulatory properties, its biological and health-related effects, as well as its isolated active ingredients e.g. beta-glucans, have been examined by scientists. Other investigations have been performed with mixed mushroom products, such as AndoSanTM, which contains mostly AbM, but also the two other mushrooms above. AbM-related benefits reviewed here include effects against cancer, infections, inflammation, allergy/ asthma and diabetes. Effects of AndoSanTM and other AbM-based extracts have been compared in a bacterial sepsis model.

Keywords: Agaricus blazei, AndoSanTM, allergy, asthma, cancer, infection, inflammation, immunomodulation.

Downloads

Published

2012-11-17

Issue

Vol. 2 No. 11 (2012): November 2012

Section

Review Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.